Winners of the 2021 CPhI Pharma Awards have now been announced

Milan, November 12, 2021: CPhI Worldwide announces the winners of the 18^th edition of the CPhI Pharma Awards, hosted live in Milan, with winners spanning some 10 distinct categories. The Awards seek to recognise ‘Excellence in Pharma’ , assessing entries from the industry leading companies and individuals.

The prestigious Excellence in Pharma: CEO of the Year Award was handed to Lynne Ann du Toit from Eurolab for her clear vision on what the future of cancer treatment in South Africa should look like. The CPhI judges selected Lynne Ann du Toit in light of her bold, forward-looking leadership.

Eitan Medical received the Award for Excellence in Pharma: Packaging & Drug Delivery, for its pre-filled and pre-loaded wearable drug delivery platform. The device is designed for easy, efficient, self-administered subcutaneous delivery of large volumes and high viscosity medications for use in homecare environments.

The Excellence in Pharma: Supply Chain, Logistics, and Distribution Awards was given to Rephine Sourcing for successfully developing a powerful Supplier Compliance Management Software. The “Rephine Catena” turns supplier qualification and daily supplier data updating into a proactive process worldwide, for the entire supply chain.

Adalvo picked up the Award for Excellence in Pharma: Sustainability for their strong commitment to the community, having undertaken a several notable actions in the last year.

Excellence in Pharma: Innovation in Response to Covid-19 was handed to Novavax. This award is in recognition of their impressive speed of committing to 1.1 billion vaccine doses of COVAX, which has a direct impact on global recovery from the pandemic.

Clarus Therapeutics received the Award for Excellence in Pharma: Finished Formulation for their first-in-class therapeutic advances in addressing unmet medical needs through the development of androgen and metabolic therapies.

Catalent excelled in the Excellence in Pharma: API Development category for their programme to boost biological drug development with significant proven output.

The Excellence in Pharma: Digital Innovation winner was Viatris for developing its real-world evidence methodology for regulatory purposes in noncommunicable diseases, artificial intelligence, machine learning and deep learning.

BASF was chosen as the winner in the Excellence in Pharma: Regulatory Procedures and Compliance category for RegXcellence®, which provides customers with easy-to-use quality and regulatory services, untangling the complexity of providing compliance documentation in support of new and existing pharmaceutical products.

Finally, Excellence in Pharma: Manufacturing Technology and Equipment was handed to Aprecia Pharmaceuticals for their latest transformative technology – the In-Cavity Powder Liquid 3D Printing solution.

­Tara Dougal, Head of Content & Insights, Informa Markets, added: “Despite the challenges of the past 18+ months, the pharmaceutical industry has shown both incredible resilience and a continued pursuit of innovation, something which is clearly reflected in the extremely high standard of entries for this year’s CPhI Pharma Awards. I’d like to thank our sponsor, Rentschler Biopharma and especially our jury, who lent their time and expertise to assessing the many entries we received. Lastly, I’d like to extend congratulations to all of the nominees for their achievements, and of course to this year’s winners!”

For more information on the CPhI Pharma Awards please visit: awards.cphi.com

Corporate Comm India (CCI Newswire)